Vilanterol Trifenate
Cat.No:IV0830 Solarbio
CAS:503070-58-4
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Endocrinology & Hormones >
Vilanterol TrifenateCAS:503070-58-4
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 503070-58-4 |
Name | Vilanterol Trifenate |
Molecular Formula | C44H49Cl2NO7 |
Molecular Weight | 774.77 |
Solubility | Soluble in DMSO ≥10mg/mL |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl |
InChIKey | KLOLZALDXGTNQE-JIDHJSLPSA-N |
InChI | InChI=1S/C24H33Cl2NO5.C20H16O2/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;21-19(22)20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h5-9,14,24,27-30H,1-4,10-13,15-17H2;1-15H,(H,21,22)/t24-;/m0./s1 |
PubChem CID | 44482554 |
Target Point | Adrenergic Receptor |
Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
Background | It is a long-acting β2-AR agonist. |
Biological Activity | Vilanterol Trifenate 是一种长效β2-肾上腺素受体(β2-AR)激动剂,具有 24 小时固有活性,对 β2-AR、β1-AR 和 β3-AR 的 pEC50 分别为 10.37、6.98 和 7.36。[1-2] |
In Vitro | Vilanterol trifenatate(vilanterol)displayed a subnanomolar affinity for the β(2)-AR,vilanterol demonstrated similar selectivity as salmeterol for β(2)- over β(1)-AR and β(3)-AR.[1] |
In Vivo | In human airways,vilanterol was shown to have a faster onset and longer duration of action than salmeterol,exhibiting a significant level of bronchodilation 22 h after treatment.[1] Vilanterol(VI; 25-100 μg; once daily,14 days)was well tolerated asthma and COPD,and produced a rapid and prolonged bronchodilation over 24 h.[2] |
Data Literature Source | [1]. Slack RJ,et al. In vitro pharmacological characterization of vilanterol,a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action. J Pharmacol Exp Ther. 2013 Jan;344(1):218-30. [2]. Kempsford R,et al. Vilanterol trifenatate,a novel inhaled long-acting beta2 adrenoceptor agonist,is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD. Pulm Pharmacol Ther. 2013 Apr;26(2):256-64. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.